Dr. Pecora on HPV Cervical Cancer Findings

Andrew L. Pecora, MD, FACP, CPE
Published: Wednesday, May 18, 2011

Andrew L. Pecora, MD, FACP, CPE the Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center on findings from the HPV Cervical Cancer Study.

Dr. Pecora says one of the first exciting things for women who are afflicted with HPV is a study that shows these women can increase the intervals between the times they are having follow up tests and don't need to rely on pap smears as much. The data from the study shows that an HPV test is sufficient to give a woman an idea of what her risks are for the subsequent development of cervical cancer.
SELECTED
LANGUAGE
Andrew L. Pecora, MD, FACP, CPE the Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center on findings from the HPV Cervical Cancer Study.

Dr. Pecora says one of the first exciting things for women who are afflicted with HPV is a study that shows these women can increase the intervals between the times they are having follow up tests and don't need to rely on pap smears as much. The data from the study shows that an HPV test is sufficient to give a woman an idea of what her risks are for the subsequent development of cervical cancer.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x